Additionally, mutant Huntingtin aggregates present in Huntington’s disease enhance microglial activation through PU.1 [35], as do hypoxic-ischaemic insults [36], suggesting that PU.1 modulation may be a common feature underlying distinct neurological disorders. This evidence concerns the gene SPI1 and nervous system disorder.